134 related articles for article (PubMed ID: 24298447)
1. Correlates of NNAL levels among nondaily and daily smokers in the college student population.
Berg CJ; Schauer GL; Ahluwalia JS; Benowitz NL
Curr Biomark Find; 2012 Oct; 2012(2):. PubMed ID: 24298447
[TBL] [Abstract][Full Text] [Related]
2. Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample.
Khariwala SS; Scheuermann TS; Berg CJ; Hayes RB; Nollen NL; Thomas JL; Guo H; Ahluwalia JS; Benowitz NL
Nicotine Tob Res; 2014 May; 16(5):600-5. PubMed ID: 24297808
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
4. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
[TBL] [Abstract][Full Text] [Related]
5. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents.
Jacob P; St Helen G; Yu L; Nardone N; Havel C; Cheung P; Benowitz NL
Nicotine Tob Res; 2020 Jun; 22(7):1107-1113. PubMed ID: 31833541
[TBL] [Abstract][Full Text] [Related]
7. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial.
Mercincavage M; Lochbuehler K; Wileyto EP; Benowitz NL; Tyndale RF; Lerman C; Strasser AA
JAMA Netw Open; 2018 Aug; 1(4):e181346. PubMed ID: 30627706
[TBL] [Abstract][Full Text] [Related]
8. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
[TBL] [Abstract][Full Text] [Related]
9. Use of and reasons for using multiple other tobacco products in daily and nondaily smokers: Associations with cigarette consumption and nicotine dependence.
Dunbar MS; Shadel WG; Tucker JS; Edelen MO
Drug Alcohol Depend; 2016 Nov; 168():156-163. PubMed ID: 27664553
[TBL] [Abstract][Full Text] [Related]
10. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.
Chaffee BW; Jacob P; Couch ET; Benowitz NL
Nicotine Tob Res; 2020 Oct; 22(10):1764-1771. PubMed ID: 31504879
[TBL] [Abstract][Full Text] [Related]
11. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
[TBL] [Abstract][Full Text] [Related]
12. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Goniewicz ML; Havel CM; Peng MW; Jacob P; Dempsey D; Yu L; Zielinska-Danch W; Koszowski B; Czogala J; Sobczak A; Benowitz NL
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3421-5. PubMed ID: 19959691
[TBL] [Abstract][Full Text] [Related]
13. Proposed cutoff for identifying adult smokeless tobacco users with urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol: an aggregated analysis of NHANES 2007-2010 data.
Agaku IT; Vardavas CI; Connolly G
Nicotine Tob Res; 2013 Nov; 15(11):1956-61. PubMed ID: 23956252
[TBL] [Abstract][Full Text] [Related]
14. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
[TBL] [Abstract][Full Text] [Related]
15. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
[TBL] [Abstract][Full Text] [Related]
16. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
[TBL] [Abstract][Full Text] [Related]
17. Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.
Piper ME; Baker TB; Benowitz NL; Kobinsky KH; Jorenby DE
Nicotine Tob Res; 2019 Aug; 21(9):1279-1284. PubMed ID: 30365010
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
19. Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.
Radwan G; Hecht SS; Carmella SG; Loffredo CA
Nicotine Tob Res; 2013 Jan; 15(1):130-8. PubMed ID: 22573723
[TBL] [Abstract][Full Text] [Related]
20. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
Carmella SG; Akerkar SA; Richie JP; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
